Homburger advised Siegfried on its acquisition of a 95% stake in DiNAMIQS
Siegfried and DiNAQOR AG entered into an agreement relating to the acquisition by Siegfried of a 95% stake in DiNAQOR DiNAMIQS AG (DiNAMIQS), a Swiss-based biotechnology company focused on the development and manufacturing of viral vectors for cell and gene therapies. Siegfried will bring DiNAMIQS’ capabilities to commercial scale and establish DiNAMIQS as a best-in-class biotech CDMO for cell and gene therapies. Through this acquisition, Siegfried further expands its footprint in the biologics space and will create significant mid to long-term growth opportunities in a very dynamic market segment.
Homburger acted as counsel to Siegfried. The team included Karin Mattle and Oriana Schöni (both Corporate/M&A), Gregor Bühler and Kristina Martinovic (both IP/IT) as well as Stefan Oesterhelt and Laetitia Fracheboud (both Tax). Daniel Hasler (Corporate/M&A) advised on the transaction as client relationship partner.